The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Hargreaves Lansdown Hit After Profit Drop

Wed, 04th Feb 2015 11:40

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
Sky, up 1.9%. The company posted a big increase in pretax profit for the first half of its financial year, boosted by a rise in revenue and exceptional gains from the sale of its stakes in ITV PLC and the National Geographic Channel. Profit was boosted by a GBP492 million gain from the sale of its 6.4% stake in ITV PLC and a GBP296 million gain from the sale of its stake in the National Geographic Channel.

Arm Holdings, up 1.6%. The chip designer announced a new suite of intellectual properties that are expected to be launched on mobile devices in 2016, including its ARM Cortex-A72 processor. The group said that in target configurations, the new processor well deliver CPU performance that is 50 times that of leading smartphones from five years ago.

Antofagasta, up 1%, Rio Tinto, up 0.4%, Glencore, up 0.4%, Fresnillo, up 1.3%, and Randgold Resources, up 0.5%, Mining shares are up after China's central bank lowered its banks' reserve requirement ratio by 0.5 percentage points in order to support lending. The gold miners are  getting a boost from a rise in the gold price to USD1,268.86.

GlaxoSmithKline, up 0.3%. Sky News reported that it has learnt that Glaxo has hired Citi, Goldman Sachs and Morgan Stanley as financial advisers on its HIV medicines joint venture ViiV Healthcare. It says the appointment of the banks will fuel the prospect of Glaxo floating the division, which analysts believe could be worth at least GBP17 billion. The shares are up ahead of the company's full year results at 1200 GMT.
-------
FTSE 100 LOSERS
-------
Hargreaves Lansdown, down 5.7%. The investment management product provider reported a drop in first-half pretax profit, despite a rise in assets under administration over the course of the six months, in what was described as a "muted" time for stocks and retail investors. The group said pretax profit declined to GBP101.9 million in the six months ended December 31 from GBP104.1 million in the corresponding period last year.

Tullow Oil, down 3.9%, BP, down 1.5% and Weir Group, down 1.4%. A drop in oil prices is dragging down oil-related stocks. Brent currently trades at USD56.44 a barrel. Moreover, Royal Dutch Shell B, down 1.9%, and Royal Shell A, down 1.5%, has suffered price target cuts. Liberum has cut the oil major price target to 2,120p from 2,230p, keeping its rating at Hold, while LBBW has cut the company's price target price target to 2,450p from 2,600p, keeping its rating at Buy.
-------
FTSE 250 WINNERS
-------
BTG, up 1.4%. Panmure has raised the Healthcare company's price target to 1,305p from 800p, keeping its rating at Buy.
-------
FTSE 250 LOSERS
-------
Afren, down 7.5% and Premier Oil, down 2.5%. Both oil-related stocks are suffering from the fall in oil prices.

Moneysupermarket.com Group, down 3.9%. Numis said the stock is overvalued against its online listed peers, based on numerous metrics, and the broker would be downbeat on the company at its current share price even without the potential threat posed by Google
-------
AIM ALL-SHARE WINNERS
-------
Camkids Group, up 38%. The China-based children's clothing company shares are up, even though it said it expects its results for the year to miss market expectations after a number of orders were cancelled in December, exacerbating existing problems the company was facing from the weaker economic environment in China. Following that warning, certain distributors for Camkids requested the postponement or cancellation of some orders totalling CNY79 million. The company said it thought its shares were being undervalued.

Dillistone Group, up 19%. Recruitment software supplier said it expects its full year results for 2014, excluding acquisition related items, will be at a similar level to 2013, and said it enters 2015 with a stronger pipeline. The company said order intake in its Systems Division rose more than 20% in the fourth quarter of 2014. It said it had won more new business contracts in December than it had in any month of the last two years.

Nostra Terra Oil and Gas Co, up 8.7%. The company said it placed four new wells into production during the fourth quarter which significantly increased production and said although its partners are cutting back on drilling activity, it will take advantage of the low oil price to try and secure further growth opportunities.

Mosman Oil and Gas, up 6.9%. The group said it has started flow testing on the Crossroads-1 well at its Petroleum Creek project in New Zealand and it has now received the technical report on the cores and cuttings from the 2014 drilling programme at Crestal-1 and Crestal-2.
-------
AIM ALL-SHARE LOSERS
-------
Craven House Capital, off 8%. Investment company said that talks over a potential investment have ended, after it had confirmed last month that talks were ongoing. "The company confirms that these discussions have been terminated," Craven House Capital said.
-------

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.